Sarepta Therapeutics
SRPT
SRPT
326 hedge funds and large institutions have $5.7B invested in Sarepta Therapeutics in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 94 increasing their positions, 121 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $6.47B → $5.7B (-$770M)
16% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 63
22% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 121
Holders
326
Holding in Top 10
5
Calls
$135M
Puts
$82.1M
Top Buyers
| 1 | +$162M | |
| 2 | +$64M | |
| 3 | +$52.6M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$43M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$36.2M |
Top Sellers
| 1 | -$105M | |
| 2 | -$52.4M | |
| 3 | -$45.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$45.4M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$44.5M |